Trials / Completed
CompletedNCT02185183
Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD)
Phase 2 Clinical Trial for Oral Administration of Alequel for Patients With IBD
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Oral administration of Alequel, a mixture of proteins derived from the patient's bowel will be tested in patients with inflammatory bowel disease.
Detailed description
Oral administration of Alequel prepared from patients biopsies will be tested in patients with inflammatory bowel disease to determine its anti inflammatory effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alequel | Alequel |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2014-07-09
- Last updated
- 2014-10-01
- Results posted
- 2014-09-22
Source: ClinicalTrials.gov record NCT02185183. Inclusion in this directory is not an endorsement.